A61L 2430/36
Materials or treatment for tissue regeneration: for embolization or occlusion
Official title: for embolization or occlusion, e.g. vaso-occlusive compositions or devices
A61L2430/36 (Materials or treatment for tissue regeneration: for embolization or occlusion) appears on 465 US grants and 761 published applications in this corpus.
Search patents in A61L- Granted patents
- 465
- Published applications
- 761
- Assignees
- 299
- Inventors
- 1,215
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 11 | 0 |
| 1998 | 8 | 0 |
| 1999 | 3 | 0 |
| 2000 | 9 | 0 |
| 2001 | 9 | 6 |
| 2002 | 10 | 20 |
| 2003 | 12 | 29 |
| 2004 | 3 | 19 |
| 2005 | 5 | 25 |
| 2006 | 9 | 25 |
| 2007 | 4 | 28 |
| 2008 | 8 | 13 |
| 2009 | 7 | 29 |
| 2010 | 9 | 19 |
| 2011 | 9 | 29 |
| 2012 | 17 | 23 |
| 2013 | 17 | 34 |
| 2014 | 14 | 24 |
| 2015 | 16 | 23 |
| 2016 | 22 | 31 |
| 2017 | 15 | 23 |
| 2018 | 23 | 34 |
| 2019 | 29 | 45 |
| 2020 | 35 | 43 |
| 2021 | 19 | 35 |
| 2022 | 31 | 41 |
| 2023 | 22 | 52 |
| 2024 | 24 | 43 |
| 2025 | 39 | 41 |
| 2026 | 14 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Biomaterial compositions and methods of delivery18 Aug 2026US 12,708,554 B2Contraline, Inc.
- Liquid embolic material composition7 Jul 2026US 12,673,127 B2The Regents of the University of California
- Microspheres containing therapeutic agents and related methods of use30 Jun 2026US 12,667,544 B2Biosphere Medical, Inc.
- Embolization hydrogel having controllable degradation time, and preparation method therefor9 Jun 2026US 12,649,015 B2Nextbiomedical Co., Ltd.
- Sclerotherapy of venous blood vessels2 Jun 2026US 12,642,884 B1Croma-Pharma GmbH
- Liquid embolic material composition8 Oct 2026US 2026/0306699 A1The Regents of the University of California
- Novel sclerotherapy of venous blood vessels10 Sep 2026US 2026/0263656 A1Croma-Pharma GmbH
- Probiotic And Cellular Graft Compositions For Uses In Tissue Rebuilding20 Aug 2026US 2026/0241060 A1Children's Healthcare of Atlanta, Inc.
- Vascular embolic system16 Jul 2026US 2026/0199545 A13-D Matrix, Ltd.
- Flowable chitosan bioadhesive hemostatic compositions that resist dissolution16 Jul 2026US 2026/0199547 A1Tricol Biomedical, Inc.
Most cited
By later US patents
- Vascular closure device1,319US 8,790,684 B2Cordis Corporation · 2014
- Injectable or implantable biomaterials for filling or blocking lumens and voids of the body846US 5,752,974 ACollagen Corporation · 1998
- Compositions for use in embolizing blood vessels643US 5,667,767 AMicro Therapeutics, Inc. · 1997
- Anatomically shaped vasoocclusive device and method of making the same551US 5,645,558 AMedical University of South Carolina · 1997
- Compositions for use in embolizing blood vessels544US 5,851,508 AMicroTherapeutics, Inc. · 1998